Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.

María Queralt SalasShruti PremEshetu G AtenafuArjun Datt LawWilson LamZeyad Al-ShaibaniDavid LoachDennis Dong Hwan KimFotios V MichelisJeffrey Howard LiptonRajat KumarJonas MattssonAuro Viswabandya

Published in: European journal of haematology (2019)

RIC allo-HSCT combined with ATG and PTCy is safe and a potentially curative strategy and it is associated with impressive GRFS in AML.

Keyphrases

stem cells
hematopoietic stem cell
stem cell transplantation
high dose
acute myeloid leukemia
bone marrow
low dose
high intensity
rectal cancer
prognostic factors
allogeneic hematopoietic stem cell transplantation
mesenchymal stem cells